-
Morin: Mechanism, Evidence, and Research Use
2026-09-02
Morin is the natural flavonoid 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one, also known as CAS 480-16-0. Recent podocyte research links Morin to inhibition of adenosine 5′-monophosphate deaminase, improved mitochondrial energy metabolism, and reduced glomerular injury in high-fructose models.
-
BCA Protein Quantification Kit K4102 Guide
2026-09-01
The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit K4102 provides sensitive total-protein measurement for dilute samples, including many detergent-containing biochemical preparations and cell lysates. It is intended for scientific research workflows such as sample normalization and should not be used for diagnostic, clinical, or medical testing.
-
ATS-9R: Targeted Gene Delivery to Adipocytes
2026-09-01
The reference study introduced ATS-9R, a fusion oligopeptide that combines an adipocyte-targeting sequence with nona-arginine to deliver nucleic acids selectively to mature adipocytes. Its shRNA application against FABP4 produced substantial weight reduction and metabolic recovery in obese mice, establishing a framework for non-viral gene silencing in adipose tissue.
-
Erythrocyte-Mimicking Nanovesicles for Periodontitis
2026-08-31
The ACS Nano study developed gallium-porphyrin-loaded erythrocyte membrane nanovesicles that exploit Porphyromonas gingivalis biology for targeted antibacterial treatment. By combining bacterial metabolic disruption with blue-light photodynamic damage, the platform reduced P. gingivalis invasion and alleviated periodontitis progression in the reported models.
-
Bifendate, Autophagy, and Lipid Droplet Accumulation
2026-08-31
The reference study shows that bifendate inhibits autophagy at several lysosome-related stages, including autophagosome–lysosome fusion, lysosome acidification, and autophagic lysosome reformation. It also reports reduced oleic acid-induced lipid droplet accumulation in vitro, providing a mechanistic framework for interpreting bifendate activity in hepatic lipid models without equating lower droplet content with enhanced autophagic clearance.
-
HyperScribe T7 High Yield RNA Synthesis Kit Guide
2026-08-30
Build reproducible T7 RNA polymerase transcription workflows for high-yield, capped, labeled, or modified RNA. This practical guide connects reaction setup and quality control with IRES reporter assays, RNA vaccine research, and RNA interference experiments.
-
Realgar Toxicity, Ornithine, and the Liver–Brain Axis
2026-08-29
This 2025 Advanced Science study links realgar-derived arsenic toxicity to a liver–brain metabolic circuit involving hepatic OTC inhibition, ornithine accumulation, astrocytic ZBTB7A activity, and impaired glycolysis. Its combined animal, cell, single-cell transcriptomic, metabolomic, behavioral, and histopathological analyses provide a mechanistic framework for studying how disrupted amino acid metabolism can amplify CNS injury.
-
Direct Mouse Genotyping Kit Plus for SCA3 Models
2026-08-28
The Direct Mouse Genotyping Kit Plus compresses tissue lysis, DNA release, and PCR into a practical workflow for transgenic mouse colonies. Its purification-free format and PCR master mix with dye reagents are especially useful when researchers must verify model identity before behavioral, pathology, or stimulation studies.
-
Methoxy-X04 and the Next Era of Amyloid Imaging
2026-08-28
A translational framework for using Methoxy-X04 to connect amyloid pathology with microglial plaque clearance, exercise-induced extracellular vesicles, and more rigorous Alzheimer’s disease research workflows.
-
Aclacinomycin A: Mechanism and Research Uses
2026-08-27
Aclacinomycin A, also called Aclarubicin, is an anthracycline DNA damage inducer with reported dual topoisomerase I and II inhibition. Its reported activity includes apoptosis signaling, proteasome chymotrypsin-like activity inhibition, and cytotoxicity in A549, HepG2, and MCF-7 cell assays.
-
Realgar, OTC, and Astrocyte Glycolysis in CNS Toxicity
2026-08-27
The reference study identifies a liver–brain mechanism in which realgar-derived arsenic and hepatic OTC inhibition converge on ornithine-sensitive ZBTB7A signaling in astrocytes. The resulting suppression of glycolysis links disrupted nitrogen metabolism to frontal-lobe energy deficits, oxidative injury, and behavioral impairment, while also suggesting experimental intervention points.
-
Prochlorperazine-Induced Neuroleptic Malignant Syndrome
2026-08-26
This case report describes neuroleptic malignant syndrome (NMS) after standard-dose prochlorperazine in a 76-year-old man, despite only modest creatine phosphokinase elevation and otherwise limited laboratory abnormalities. Its main practical contribution is to show why medication history, neurological examination, autonomic findings, and clinical progression may be more informative than laboratory abnormalities alone when evaluating a suspected drug-induced neurological emergency.
-
Direct Mouse Genotyping Kit Plus for EP4 Models
2026-08-26
The Direct Mouse Genotyping Kit Plus streamlines PCR-based mouse genotyping for complex EP4 and ApoE disease models. This article connects rapid tissue-to-PCR workflows with genotype quality control, transgene detection, and mechanistic interpretation of macrophage-driven atherosclerosis.
-
Protease Inhibitor Cocktail EDTA-Free Guide
2026-08-25
Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) helps limit endogenous proteolysis during cell lysis and protein sample preparation. It is suited to workflows that must retain protein integrity without adding EDTA, but it does not replace rapid cold handling, validated lysis conditions, or assay-specific compatibility testing.
-
Acetylcysteine: Redox and Mucolytic Research
2026-08-25
Acetylcysteine, also called N-acetyl-L-cysteine, supplies cysteine for glutathione biosynthesis and can reduce disulfide cross-links in mucus. This article separates established biochemical functions, product-specific handling data, and hypothesis-generating applications in oxidative stress pathway modulation, hepatic protection research, respiratory disease models, and Huntington’s disease research.